Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Hypocretin-1 deficiency in a girl with ROHHAD syndrome.

Dhondt K, Verloo P, Verhelst H, Van Coster R, Overeem S.

Pediatrics. 2013 Sep;132(3):e788-92. doi: 10.1542/peds.2012-3225. Epub 2013 Aug 12.

2.

Hypocretin deficiency develops during onset of human narcolepsy with cataplexy.

Savvidou A, Knudsen S, Olsson-Engman M, Gammeltoft S, Jennum P, Palm L.

Sleep. 2013 Jan 1;36(1):147-8. doi: 10.5665/sleep.2320.

3.

The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.

Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, Overeem S, Vankova J, Black J, Harsh J, Bassetti C, Schrader H, Nishino S.

Arch Neurol. 2002 Oct;59(10):1553-62.

PMID:
12374492
4.

[Narcolepsy: a new perspective on diagnosis and treatment].

Fronczek R, van der Zande WL, van Dijk JG, Overeem S, Lammers GJ.

Ned Tijdschr Geneeskd. 2007 Apr 14;151(15):856-61. Review. Dutch. Erratum in: Ned Tijdschr Geneeskd. 2007 Jun 2;151(22):1260.

PMID:
17472116
5.

Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.

Baumann CR, Khatami R, Werth E, Bassetti CL.

J Neurol Neurosurg Psychiatry. 2006 Mar;77(3):402-4.

6.
7.

Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.

Knudsen S, Gammeltoft S, Jennum PJ.

Brain. 2010 Feb;133(Pt 2):568-79. doi: 10.1093/brain/awp320. Epub 2010 Feb 3.

PMID:
20129934
8.

The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).

Bassetti C, Gugger M, Bischof M, Mathis J, Sturzenegger C, Werth E, Radanov B, Ripley B, Nishino S, Mignot E.

Sleep Med. 2003 Jan;4(1):7-12.

PMID:
14592354
9.

Nocturnal rapid eye movement sleep latency for identifying patients with narcolepsy/hypocretin deficiency.

Andlauer O, Moore H, Jouhier L, Drake C, Peppard PE, Han F, Hong SC, Poli F, Plazzi G, O'Hara R, Haffen E, Roth T, Young T, Mignot E.

JAMA Neurol. 2013 Jul;70(7):891-902. doi: 10.1001/jamaneurol.2013.1589. Erratum in: JAMA Neurol. 2013 Oct;70(10):1332.

10.

Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy.

Andlauer O, Moore H 4th, Hong SC, Dauvilliers Y, Kanbayashi T, Nishino S, Han F, Silber MH, Rico T, Einen M, Kornum BR, Jennum P, Knudsen S, Nevsimalova S, Poli F, Plazzi G, Mignot E.

Sleep. 2012 Sep 1;35(9):1247-55F. doi: 10.5665/sleep.2080.

11.

Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation.

Grimaldi D, Agati P, Pierangeli G, Franceschini C, Guaraldi P, Barletta G, Vandi S, Cevoli S, Plazzi G, Montagna P, Cortelli P.

Chronobiol Int. 2010 Sep;27(8):1596-608. doi: 10.3109/07420528.2010.504907.

PMID:
20854137
12.

Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?

Wienecke M, Werth E, Poryazova R, Baumann-Vogel H, Bassetti CL, Weller M, Waldvogel D, Storch A, Baumann CR.

J Sleep Res. 2012 Dec;21(6):710-7. doi: 10.1111/j.1365-2869.2012.01027.x. Epub 2012 Jul 2.

13.

Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy.

Overeem S, Scammell TE, Lammers GJ.

Curr Opin Neurol. 2002 Dec;15(6):739-45. Review.

PMID:
12447114
14.

Sleep transitions in hypocretin-deficient narcolepsy.

Sorensen GL, Knudsen S, Jennum P.

Sleep. 2013 Aug 1;36(8):1173-7. doi: 10.5665/sleep.2880.

15.

Narcolepsy in the older adult: epidemiology, diagnosis and management.

Chakravorty SS, Rye DB.

Drugs Aging. 2003;20(5):361-76. Review.

PMID:
12696996
16.

Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives.

Overeem S, Mignot E, van Dijk JG, Lammers GJ.

J Clin Neurophysiol. 2001 Mar;18(2):78-105. Review.

PMID:
11435802
17.

[Narcolepsy with cataplexy].

Dauvilliers Y, Arnulf I.

Rev Neurol (Paris). 2008 Aug-Sep;164(8-9):634-45. doi: 10.1016/j.neurol.2007.08.012. Epub 2008 Mar 4. Review. French.

PMID:
18805301
18.

[Narcolepsy--new implications of molecular biology].

Knudsen S, Jennum PJ.

Ugeskr Laeger. 2006 Oct 23;168(43):3699-704. Review. Danish.

PMID:
17069732
19.

A case of rapid-onset obesity with hypothalamic dysfunction, hypoventilation, autonomic dysregulation, and neural crest tumor: ROHHADNET syndrome.

Abaci A, Catli G, Bayram E, Koroglu T, Olgun HN, Mutafoglu K, Hiz AS, Cakmakci H, Bober E.

Endocr Pract. 2013 Jan-Feb;19(1):e12-6. doi: 10.4158/EP12140.CR.

PMID:
23186956
20.

Sleepiness that cannot be overcome: narcolepsy and cataplexy.

Han F.

Respirology. 2012 Nov;17(8):1157-65. doi: 10.1111/j.1440-1843.2012.02178.x. Review.

PMID:
22471619

Supplemental Content

Support Center